Valuation: Genpharmasec Limited

Market Cap 432M 4.48M 3.94M 3.66M 3.36M 6.32M 6.41M 43.5M 17M 212M 16.84M 16.47M 734M P/E 2024
-545x
P/E 2025 94.5x
Enterprise Value 422M 4.39M 3.85M 3.58M 3.29M 6.18M 6.27M 42.55M 16.63M 208M 16.47M 16.11M 718M EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
56.99%
Yield 2024 *
-
Yield 2025 -
1 day-0.97%
Current month-7.27%
1 month-10.53%
3 months-19.05%
6 months-15.00%
Current year-22.14%
1 week 1
Extreme 1
1.08
1 month 1
Extreme 1
1.19
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.2
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
12.4
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 38 2022-10-31
Compliance Officer - 2024-03-26
Director TitleAgeSince
Director/Board Member 57 2019-01-01
Director/Board Member 58 2019-01-01
Director/Board Member - 2022-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.97%0.00%-49.75%-68.52% 5.89M
+2.29%+2.36%-17.97%-10.09% 175B
+1.46%+0.01%-9.87%-6.25% 105B
+1.58%+0.65%+6.69%+61.86% 59.35B
-1.13%-2.60%+26.37%+54.76% 50.71B
+2.22%-1.14%-14.85%-44.15% 42.15B
+2.98%-2.61% - - 31.82B
+1.50%-6.67%-17.52%-43.99% 27.2B
-7.67%-8.39%+17.59%-12.73% 25.11B
+1.63%-1.73%-5.80%-7.80% 20.53B
Average +0.39%-1.45%-7.23%-8.54% 53.73B
Weighted average by Cap. +1.23%-0.15%-6.40%+0.96%

Financials

2024 2025
Net sales 304M 3.16M 2.77M 2.58M 2.37M 4.45M 4.52M 30.62M 11.96M 149M 11.85M 11.6M 517M 337M 3.5M 3.08M 2.86M 2.62M 4.93M 5.01M 33.96M 13.27M 166M 13.15M 12.86M 573M
Net income -1.26M -13.05K -11.46K -10.66K -9.78K -18.38K -18.67K -127K -49.46K -618K -49K -47.94K -2.14M 12.31M 128K 112K 104K 95.83K 180K 183K 1.24M 484K 6.05M 480K 470K 20.93M
Net Debt -179M -1.86M -1.63M -1.52M -1.39M -2.62M -2.66M -18.02M -7.04M -87.94M -6.97M -6.82M -304M -9.4M -97.64K -85.76K -79.75K -73.18K -138K -140K -947K -370K -4.62M -367K -359K -15.98M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
26-07-24 ₹1.020 -0.97% 292,175
26-07-23 ₹1.030 -3.74% 413,733
26-07-22 ₹1.070 0.00% 985,296
26-07-21 ₹1.070 +1.90% 135,832
26-07-20 ₹1.050 +2.94% 214,277
  1. Stock Market
  2. Stocks
  3. 531592 Stock